4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ)
$12.31 -0.58 (-4.4996%)
Analysed 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) News Sources
4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy
17-05-2026
marketbeat.com
4D Molecular Therapeutics Inc (FDMT): Gene Therapy Stock Made for You?
20-05-2026
yahoo.com
4DMT to Participate in Upcoming Investor Conferences
27-05-2026
yahoo.com
Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight
27-05-2026
yahoo.com
4DMT Announces New Employment Inducement Grants
12-06-2026
yahoo.com
Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?
23-06-2026
yahoo.com
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
26-06-2026
yahoo.com
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
29-06-2026
yahoo.com
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
29-06-2026
yahoo.com
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
30-06-2026
yahoo.com
What is the current price of 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ)?
The current price of 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) is $12.31.
4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) since the previous trading day is $-0.58.
4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) since the previous trading day is -4.4996%.
What is the most recent average sentiment score for 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ)?
The most recent average sentiment score for 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ)?
The most recent sentiment for 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ) is .
SEC-8K** Filing Available For 4D MOLECULAR THERAPEUTICS IN (FDMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.